If you thought I was bluffing about auto defects in the last issue, I have a sad surprise for you. Three more auto manufacturers decided to prove me right and are now being investigated over potential transmission defects. In this issue, we also take a closer look at the litigation surrounding a couple of big-name pharmaceuticals, touching on recalled blood pressure drugs and the ongoing opioid crisis. Read on for more.
First on the docket, the Ford F-150. Drivers have reported transmission issues when starting their trucks, accelerating, or shifting gears. The most common descriptions of the problem range from a loud “clunking” noise when starting the car to feeling like the transmission is “slipping,” “jerky,” or “rough.” According to several complaints, when owners bring their cars in for service, dealerships are claiming that the clunking noises are “normal” and that drivers should just ignore it. There has yet to be a recall issued over the problems customers described. But, attorneys are now looking to see if a potential class action can be filed to compensate 2017, 2018, and 2019 Ford F-150 owners. If this sounds like something you’ve experienced, keep reading to see if you can help get the litigation started.
Convenient for our ongoing theme and inconvenient for drivers, Toyota and Lexus join the list of automakers under investigation for selling cars with potentially defective transmissions. Specifically, drivers have reported issues in the 2018-2020 models of the following vehicles: Toyota Highlander, Toyota Sienna, Toyota Avalon, Lexus ES 350, Lexus RX 350, and Lexus GS 350. Problems with shifting, acceleration, and even premature transmission failure have all been reported. A lawsuit hasn’t been filed yet, but if started, could help drivers seek money for their repair costs and force Toyota and Lexus to fix the problem. You can find all the information you need here.
Our settlements page is always being updated. Have you checked to see if you're covered by any open settlements? You can also check out the latest settlements as they happen by following us on Twitter.
Over the past year, close to two dozen recalls have been issued for generic high blood pressure medication over concerns that the drugs were contaminated with potentially cancer-causing nitrosamines. These recalled drugs are now the subject of a recent wave of litigation that continues to grow, so we’re here to help you navigate the recalls, the lawsuits and how it all affects you. In this blog post you’ll be able to find out which drugs were contaminated, what you can do if you took one of these drugs, and other things you’ll need to know – and all in more detail than I can incorporate here.
The opioid epidemic has been a big story for a while now and lawsuits continue to be filed to hold Big Pharma accountable. Since the lawsuits are focusing on the health crisis itself, it’s easy to assume that people who actually took the drugs are the ones filing the cases – but that isn’t exactly how 99% of them are shaking out. A vast majority of the lawsuits have been filed by states, cities, counties, state attorneys general and Native American tribal councils instead of the victims themselves. We spoke to an attorney involved in the litigation who explained to us why this is the case. If you’re interested in taking a peek behind the scenes, head over to our blog.
~ Forward to a friend ~
Know someone who might be interested in our newsletter? Why not forward this email to them?